newsfilter
← Latest News
GlobeNewswire·

ObsEva Announces Dismissal of Moratorium Proceedings

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 19, 2022 – ObsEva SA (NASDAQ:OBSV, SIX: OBSN)), a biopharmaceutical company developing and commercializing novel